Lobbying

Zimmer Biomet ZBH's latest lobbying report covers Q2 2026, at $240K. The four quarters Q4 2025–Q3 2026 total $695K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Taxation/Internal Revenue Code.

Zimmer BiometZBH

Zimmer Biomet stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$695K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Zimmer Biomet lobbying by quarter
Zimmer Biomet lobbying by quarter
QuarterAmountReports
Q4 2022$140K2
Q1 2023$170K2
Q2 2023$120K2
Q3 2023$210K2
Q4 2023$220K2
Q1 2024$210K2
Q2 2024$230K2
Q3 2024$230K2
Q4 2024$230K2
Q1 2025$240K2
Q2 2025$240K2
Q3 2025$220K2
Q4 2025$220K2
Q1 2026$235K2
Q2 2026$240K2
Q3 2026$00

By issue

  • Medicare and Medicaid$739.1K · 30 reports
  • Taxation$604.1K · 24 reports
  • Health issues$530K · 22 reports
  • Trade$444.1K · 14 reports
  • Science and technology$198.3K · 8 reports
  • Intelligence and surveillance$145.5K · 4 reports
  • Chemicals$116.3K · 4 reports
  • Disaster planning and emergencies$98K · 3 reports
  • Medical research and clinical labs$95.6K · 4 reports
  • Environment and Superfund$60K · 2 reports
  • Food industry$39.3K · 2 reports
  • Tariffs$27.1K · 1 reports
  • Government issues$24.3K · 1 reports
  • Budget and appropriations$16.7K · 1 reports
  • Manufacturing$16.7K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES30 reports
  • SENATE30 reports

Firms it paid

Firm
In-houseZimmer Biomet$2.5M15 quarters
The McManus Group$660K15 quarters

Former officials lobbying for it

Former position
JOHN MCMANUSStaff Director W&M Health Subcommittee; LA, Rep. Bill Thomas.Q1 2024
ALANNA TEMMELD, Rep. Jon PorterQ4 2023

Lobbying reports

Filed by
07/20for Q2The McManus Group$50K
07/15for Q2In-house$190K
04/20for Q1The McManus Group$50K
04/19for Q1In-house$185K
01/20for Q4 2025The McManus Group$50K
01/15for Q4 2025In-house$170K
25/10/20for Q3 2025The McManus Group$50K
25/10/17for Q3 2025In-house$170K
25/07/21for Q2 2025The McManus Group$50K
25/07/15for Q2 2025In-house$190K
25/04/21for Q1 2025The McManus Group$50K
25/04/20for Q1 2025In-house$190K
25/01/21for Q4 2024The McManus Group$40K
25/01/13for Q4 2024In-house$190K
24/10/21for Q3 2024The McManus Group$40K
24/10/16for Q3 2024In-house$190K
24/07/18for Q2 2024In-house$190K
24/07/16for Q2 2024The McManus Group$40K
24/04/22for Q1 2024The McManus Group$40K
24/04/18for Q1 2024In-house$170K